Blood Cancer United Inc
74% goes to programs $16 to raise $100 Strong reserves Declining revenue
Blood Cancer United Inc is a 501(c)(3) organization based in Washington, District of Columbia, registered in 2001, with $358,698,504 in FY2024 revenue. CharityIndex grades it B+, and it directs about 74% of spending to programs.
1201 15th St Nw Ste 410, Washington, DC, 20005 EIN 13-5644916 Since 2001
Revenue (FY2024)
$358.7M
▼ 2.6% vs prior year
Diseases median: $206K
Expenses (FY2024)
$398.1M
Net assets
$360.5M
Employees
1,390
CharityIndex rating
One independent A+ to F grade from four published criteria, each scored separately from IRS filings and combined by weight.
B+
BProgram efficiency40% of the rating74% to programs · $16 to raise $100
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Blood Cancer United Inc: 74% to programs · $16 to raise $100 earns a B on this criterion. See the exact thresholds →
C+Financial health25% of the rating11 mo reserves · -11% margin
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Blood Cancer United Inc: 11 mo reserves · -11% margin earns a C+ on this criterion. See the exact thresholds →
A+Governance25% of the rating6 of 6 checks met
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Blood Cancer United Inc: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
A+Transparency10% of the rating5 of 5 disclosure signals
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Blood Cancer United Inc: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Mission
Cure leukemia,lymphoma,hodgkin's disease, myeloma; improve quality of life of patients and families.
What they do
B) patient & community services:an estimated 1.7 million people across the united states (us) are currently living with or are in remission from leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative neoplasms. blood cancer united offers an array of free, comprehensive resources to blood cancer patients, caregivers, families and friends ofpatients, advocates, healthcare professionals and the public. blood cancer united is committed to providing the most accurate and up-to-date blood cancer information. professional volunteer clinical advisors work with blood cancer united staff to review all of the information blood cancer united provides through healthcare professional and patient education programs, publications and the blood cancer united website. support services are provided by professionals or rigorously trained peer volunteers. all resources are provided through a variety of media - print, online, by phone, and face-to-face in communities. a number of resources are available in spanish for patients, caregivers and healthcare professionals.financial assistance our financial assistance programs aim to lessen the economic toll on patients and families to help patients afford life-saving treatments. to counter continually rising drug prices and alleviate the burdens felt by patients coping with blood cancer, blood cancer united provided 69,120 grants totaling over $162m in assistance awarded. the majority, $153m, supported patients' insurance premiums, treatment-related co-pays, and co-insurance out of pocket costs through our co-pay assistance program. in keeping with our commitment to diversity, equity, and inclusion, blood cancer united recognizes that need exists throughout all geographic regions and within all patient populations, including those traditionally underrepresented. co-pay assistance program the co-pay assistance program supports qualifying blood cancer patients meet their health insurance or medicare plan part b or d premiums or co-payment obligations related to treating their blood cancer diagnosis. patients with prescription drug coverage, medicare beneficiaries under medicare part b and/or medicare part d, medicare supplementary health insurance or medicare advantage should check with blood cancer united to see if they meet eligibility requirements to receive financial support. co-pay assistance is subject to funding availability by specific blood cancer diagnosis. in 2025, blood cancer united awarded 35,302 grants through its co-pay assistance program. susan lang pre car t-cell therapy travel assistance program blood cancer united awarded 270 grants each in the amount of $2,500 for treatment-related transportation and lodging costs for patients who are being evaluated to receive car t-cell therapy as either standard treatment or a clinical trial. susan lang pay-it-forward patient travel assistance program blood cancer united awarded 2,040 grants each in the amount of $500 for treatment-related transportation and lodging costs. urgent need program in partnership with moppie's love and charlie's fund, blood cancer united awarded 9,119 grants each in the amount of $500 for non-medical living expenses-including rent, utilities, and food. local financial assistance program blood cancer united awarded 989 grants each in the amount of $500 to cover non-medical living expenses-including rent, utilities, and food, etc.patient aid program blood cancer united awarded one-time stipends of $100 to over 20,345 patients to help offset non-medical expenses. patient aid helene & milton blood cancer united awarded one-time stipends of $100 to 1055 patients who resided in designated zip codes declared for individualassistance by fema, to alleviate financial hardship as a result of the hurricanes. medical debt case management program blood cancer united's medical debt case management program provides one-on-one, personalized support to empower patients to address their medical debt in the following
Contact & location
- Address
- 1201 15th St Nw Ste 410, Washington, DC, 20005
- City
- Washington
- State
- District of Columbia
- Subcategory
- Cancer
- Phone
- …
- Website
- …
Financial trends
Revenue grew from $310.1M (FY2013) to $358.7M (FY2024) across 12 reported years.
Financial snapshot
Financial health & position (FY2024)
Liabilities $171.7MNet assets $360.5M
Operating margin
-11.0%
Spent more than it raised in the latest fiscal year.
Total assets
$532.2M
Total liabilities
$171.7M
Net assets
$360.5M
Salaries & benefits
$154.6M
39% of expenses
Board members
23
19 independent
Financials by year
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $358,698,504▼2.6% | $398,128,476▲7.1% | $360,496,943▼7.8% | $532,209,663▼11.6% | 990 |
| 2023 | $368,242,059▼2.7% | $371,792,172▼3.7% | $390,952,181▲4.9% | $602,010,519▼6.5% | 990 |
| 2022 | $378,338,490▼11.4% | $386,072,968▼25.6% | $372,553,568▲0.2% | $643,891,871▼7.2% | 990 |
| 2021 | $426,997,204▼10.6% | $518,622,394▲44.1% | $371,943,462▼27.6% | $693,676,206▼6.7% | 990 |
| 2020 | $477,663,716▼3.7% | $359,848,179▼8.7% | $513,772,498▲40.3% | $743,613,782▲27.8% | 990 |
| 2019 | $496,221,309▲25.2% | $393,996,450▲7.3% | $366,122,438▲36.4% | $581,677,610▲28.1% | 990 |
| 2018 | $396,221,152▼9.7% | $367,321,473▲3.0% | $268,391,389▲13.6% | $454,102,204▲18.8% | 990 |
| 2017 | $438,854,761▲27.1% | $356,450,352▲13.0% | $236,232,374▲55.1% | $382,344,839▲40.4% | 990 |
| 2016 | $345,298,600▲27.1% | $315,486,013▲23.8% | $152,287,725▲29.0% | $272,265,949▲25.4% | 990 |
| 2015 | $271,727,274▼3.5% | $254,769,311▼8.2% | $118,080,301▲21.1% | $217,192,867▲1.3% | 990 |
| 2014 | $281,628,930▼9.2% | $277,443,057▼12.5% | $97,521,946▲0.4% | $214,485,806▼11.6% | 990 |
| 2013 | $310,095,987 | $317,198,282▲3.3% | $97,137,108▼3.8% | $242,581,527▲2.6% | 990 |
| 2012 | — | $306,978,665▲5.0% | $101,009,433▼11.4% | $236,325,556▲5.8% | 990 |
| 2011 | — | $292,394,514▲4.1% | $114,048,779▼4.8% | $223,445,924▼0.4% | 990 |
| 2010 | — | $280,841,124▲12.1% | $119,783,893▲9.4% | $224,271,874▲1.2% | 990 |
| 2009 | — | $250,482,341 | $109,447,069 | $221,660,340 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Leadership & compensation (FY2024)
Highest-paid: E Anders Kolb — $879,998 (0.22% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| E Anders Kolb | President & Ceo | 40 | $879,998 |
| Gwen Nichols | Evp, Chief Med Officer | 40 | $736,394 |
| Gordon Miller | Evp, Chief Fin Officer | 40 | $648,480 |
| Dale Nissenbaum | Former Evp, Gen Cnsl - End 05/2024 | 40 | $547,759 |
| Flora Coker Powell | Evp, Chief Rev Officer | 40 | $512,813 |
| Susan Brown | Svp, Chief Sus Off End - 11/12/2024 | 40 | $421,797 |
| Lee Greenberger | Svp, Chief Sci Officer - End 12/2024 | 40 | $408,560 |
| Florence Godfrey | Svp, Chief Experience Officer | 40 | $406,318 |
| Andrew Perry | Svp, Bus Ops and Technology | 40 | $391,677 |
| Elisa Weiss | Svp, Education | 40 | $367,828 |
| Meredith Fogel | Evp, Gen Counsel - Start 09/2024 | 40 | $312,368 |
| Troy Dunmire | Former Evp, Cf Op Off - End 01/2024 | 40 | $263,181 |
| Shonette Harrison Carew | Evp, Chief Admin Off - Start 09/2024 | 40 | $162,265 |
| Orlando Ashworth | Evp, Chief People - Start 10/2024 | 40 | $95,040 |
| Alessandra Tocco | Chair | 4 | — |
| Alex Okafor | Bod Member | 4 | — |
| Ari Melnick | Bod Member | 4 | — |
| Freda Wang | Vice Chair | 4 | — |
| Janice Gabrilove Md | At Large | 4 | — |
| Jeff Sachs | Bod Member | 4 | — |
Top vendors & contractors (FY2024)
| Contractor | Services | Paid |
|---|---|---|
| Icon Plc - Pharmaceutical Research Assoc | Clinical Trial | $9,616,721 |
| Patient Advocate Foundation | Pat Assist Proc | $6,765,372 |
| Moore A Series LLC | Professional Fundraising | $4,664,047 |
| Salesforce | Software | $4,565,999 |
| Kapadi | Clinical Trial | $3,123,545 |
Grants received · $162.9M total
1,921 grants to Blood Cancer United Inc totaling $162.9M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Paypal Charitable Giving Fund | General support | 2024 | $4,944,502 |
| American Online Giving Foundation Inc | General support | 2024 | $4,921,663 |
| Charities Aid Foundation America | Charitable donation | 2024 | $3,643,964 |
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2024 | $529,000 |
| American Endowment Foundation | Disease/disorder | 2024 | $463,464 |
| Gs Donor Advised Philanthropy Fund For Wealth Management Inc | Medical / public services | 2024 | $427,479 |
| National Christian Charitable Foundation | Medical research | 2024 | $410,130 |
| The Rhode Island Community Foundation | Hl - healthy lives (primary) | 2024 | $300,000 |
| The Blackbaud Giving Fund | General support | 2024 | $219,567 |
| Greater Horizons | Health, medicine & science | 2024 | $184,674 |
| The Us Charitable Gift Trust | For recipient's exempt purpose | 2024 | $129,850 |
| Ayco Charitable Foundation | Medical / public services | 2024 | $122,012 |
| Greater Milwaukee Foundation Inc | Groundbreaking research in myeloma: advancing cures and health equity | 2024 | $116,851 |
| University of Miami | General support | 2024 | $100,000 |
| The Nemours Foundation | Donation | 2024 | $100,000 |
Grants made · $47.7M in FY2024
67 grants totaling $47.7M in FY2024 — showing the 15 largest. All grants made by Blood Cancer United Inc →
| Recipient | Purpose | Amount |
|---|---|---|
| Dana-farber Cancer Institute | Research grant | $5,197,687 |
| The University of Texas Md Anderson Cancer Center | Research grant | $2,518,448 |
| Memorial Sloan-kettering Cancer Center | Research grant | $2,513,800 |
| The Board of Trustees of the Leland Stanford Junior University | Research grant | $2,257,440 |
| Washington University | Research grant | $2,252,023 |
| Joan & Sanford I Weill Medical College of Cornell University | Research grant | $2,115,000 |
| University of Florida | Research grant | $2,009,874 |
| Regents of the University of Colorado | Research grant | $1,966,500 |
| Emory University | Research grant | $1,661,071 |
| Fred Hutchinson Cancer Center | Research grant | $1,550,000 |
| H Lee Moffitt Cancer Center and Research Institute Hospital Inc | Research grant | $1,312,498 |
| St Jude Childrens Research Hospital Inc | Research grant | $1,308,000 |
| University of Miami | Research grant | $1,280,887 |
| Trustees of Columbia University | Research grant | $1,173,600 |
| Mass General Brigham Incorporated | Research grant | $1,073,600 |
Similar organizations in Diseases
Diseases
American College of Cardiology Foundation
Washington, DC
$125.8M
Aannual revenue
Diseases
American Society of Hematology Inc
Washington, DC
$118.7M
Aannual revenue
Diseases
Whitman-walker Clinic Inc
Washington, DC
$62.4M
Aannual revenue
Diseases
Optical Society of America Inc
Washington, DC
$61.8M
Aannual revenue
Diseases
Autism Speaks Inc
Washington, DC
$28.8M
B+annual revenue
Diseases
Endocrine Society
Washington, DC
$27.3M
Bannual revenue
Diseases
Food & Friends Inc
Washington, DC
$23.4M
Bannual revenue
Diseases
Melanoma Research Alliance Foundation
Washington, DC
$16.5M
Bannual revenue
Diseases
Lupus Foundation of America Inc
Washington, DC
$15.4M
C+annual revenue
Diseases
Acog Foundation
Washington, DC
$13.2M
Bannual revenue
Compare Blood Cancer United Inc
Frequently asked questions
- Is Blood Cancer United Inc a legitimate nonprofit?
- Yes. Blood Cancer United Inc is a 501(c)(3) organization registered with the U.S. Internal Revenue Service under EIN 13-5644916, based in Washington, District of Columbia. Donations are tax-deductible.
- What is Blood Cancer United Inc's EIN?
- Blood Cancer United Inc's Employer Identification Number (EIN) is 13-5644916.
- How much revenue does Blood Cancer United Inc report?
- Blood Cancer United Inc reported $358,698,504 in total revenue on its fiscal year 2024 IRS Form 990 filing.
- How much of Blood Cancer United Inc's spending goes to programs?
- Blood Cancer United Inc spends about 74% of its total expenses on programs, based on its latest IRS Form 990.
- What financial grade does Blood Cancer United Inc have?
- CharityIndex grades Blood Cancer United Inc B+, based on program efficiency and fundraising cost.
- How much does Blood Cancer United Inc's highest-paid employee make?
- The highest reported compensation on Blood Cancer United Inc's latest Form 990 is $879,998, paid to E Anders Kolb (President & Ceo).
More nonprofits in Washington
Explore more
Data for Blood Cancer United Inc (EIN 13-5644916) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.